Implantable cardioverter/defibrillator interventions in primary prevention: do current implantation criteria really predict ICD interventions?

被引:1
作者
Cools, Thijs [1 ]
Rossenbacker, Tom [1 ]
Flore, Vincent [1 ]
Nuyens, Dieter [1 ]
Heidbuchel, Hein [1 ]
Willems, Rik [1 ]
机构
[1] Univ Hosp Leuven, BE-3000 Leuven, Belgium
关键词
Implantable cardioverter/defibrillator; primary prevention; sudden death; SUDDEN CARDIAC DEATH; LEFT-VENTRICULAR FUNCTION; CARDIOVERTER-DEFIBRILLATORS; MYOCARDIAL-INFARCTION; RISK STRATIFICATION; COST-EFFECTIVENESS; RESYNCHRONIZATION THERAPY; PROPHYLACTIC IMPLANTATION; AUTOMATIC DEFIBRILLATOR; SURVIVAL;
D O I
10.1080/AC.66.2.2071244
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Randomized controlled trials have proven the efficacy of implantable cardioverter/defibrillators (ICDs) to prevent sudden cardiac death (SO) in primary prevention. However, long-term data on the incidence of appropriate and inappropriate interventions in real life and on the predictive value of commonly used clinical variables to guide patient selection are scarce. Methods We retrospectively studied 101 patients who received an ICD for primary prophylaxis of SCD: 63.4% with ischaemic heart disease (IHD) and 36.6% with idiopathic dilated cardiomyopathy (IDCM). The mean follow-up period was 26.2 (+/- 14.8; median 27.8; range 5.6-70.5) months. Age, left ventricular ejection fraction (LVEF), QRS duration, NYHA class and electrophysiological study (EPS) outcome were evaluated as predictors of ICD intervention. Results At 2 years the cumulative incidence of appropriate (17.5% in IHD; 28% in IDCM; P=0.63) and inappropriate (12.8% in IHD, 15.4% in IDCM; P=0.62) interventions was similar in both groups. Atrial fibrillation was the most common cause of inappropriate interventions in the IHD group, sinus tachycardia in the IDCM group. Advanced age was associated with less inappropriate interventions (HR: 0.96 (95% confidence interval (CI) 0.94-0.98); P<0.01), and a better LVEF with less appropriate interventions (HR: 0.97 (95% CI 0.94-0.99); P<0.01). This amounted in a significant absolute difference in the number of appropriate interventions between the group with a LVEF <25% and 25-34% after 3 years of follow-up of 42% in IHD (48% vs 6%). A prolonged QRS duration was associated with a slightly elevated risk for appropriate interventions only in the IHD group (HR: 1.01 (95% CI 1.00-1.03); P=0.04). On the other hand, increased NYHA class was only associated with increased risk for appropriate interventions in the IDCM group (HR: 5.24 (95% CI 1.11-24.74); P=0.04). No significant statistical association was found between a positive EPS and appropriate or inappropriate interventions. Conclusions In primary prevention, during a mean follow-up of 2 years, one in five patients had a possibly live-saving appropriate intervention. However, the incidence of inappropriate interventions was substantial. Predictors for appropriate interventions were: (i) LVEF in the total study group, (ii) NYHA class in the IDCM group and (iii) QRS duration in the IHD group.
引用
收藏
页码:145 / 151
页数:7
相关论文
共 31 条
[1]   Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [J].
Bardy, GH ;
Lee, KL ;
Mark, DB ;
Poole, JE ;
Packer, DL ;
Boineau, R ;
Domanski, M ;
Troutman, C ;
Anderson, J ;
Johnson, G ;
McNulty, SE ;
Clapp-Channing, N ;
Davidson-Ray, LD ;
Fraulo, ES ;
Fishbein, DP ;
Luceri, RM ;
Ip, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :225-237
[2]   Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure [J].
Bristow, MR ;
Saxon, LA ;
Boehmer, J ;
Krueger, S ;
Kass, DA ;
De Marco, T ;
Carson, P ;
DiCarlo, L ;
DeMets, D ;
White, BG ;
DeVries, DW ;
Feldman, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2140-2150
[3]   A randomized study of the prevention of sudden death in patients with coronary artery disease [J].
Buxton, AE ;
Lee, KL ;
Fisher, JD ;
Josephson, ME ;
Prystowsky, EN ;
Hafley, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25) :1882-1890
[4]   Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death [J].
Buxton, AE ;
Lee, KL ;
DiCarlo, L ;
Gold, MR ;
Greer, GS ;
Prystowsky, EN ;
O'Toole, MF ;
Tang, A ;
Fisher, JD ;
Coromilas, J ;
Talajic, M ;
Hafley, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (26) :1937-1945
[5]   The ABCD (Alternans Before Cardioverter Defibrillator) Trial [J].
Costantini, Otto ;
Hohnloser, Stefan H. ;
Kirk, Malcolm M. ;
Lerman, Bruce B. ;
Baker, James H., II ;
Sethuraman, Barathi ;
Dettmer, Mary M. ;
Rosenbaum, David S. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (06) :471-479
[6]   Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population [J].
Cowie, Martin R. ;
Marshall, Deborah ;
Drummond, Michael ;
Ferko, Nicole ;
Maschio, Michael ;
Ekman, Matthias ;
de Roy, Luc ;
Heidbuchel, Hein ;
Verboven, Yves ;
Braunschweig, Frieder ;
Linde, Cecilia ;
Boriani, Giuseppe .
EUROPACE, 2009, 11 (06) :716-726
[7]   Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy - A meta-analysis of randomized controlled trials [J].
Desai, AS ;
Fang, JC ;
Maisel, WH ;
Baughman, KL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (23) :2874-2879
[8]   Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II) [J].
Dhar, Ritesh ;
Alsheikh-Ali, Alawi A. ;
Estes, N. A. Mark, III ;
Moss, Arthur J. ;
Zareba, Wojciech ;
Daubert, James P. ;
Greenberg, Henry ;
Case, Robert B. ;
Kent, David M. .
HEART RHYTHM, 2008, 5 (06) :807-813
[9]   Systematic review: Implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction [J].
Ezekowitz, Justin A. ;
Rowe, Brian H. ;
Dryden, Donna M. ;
Hooton, Nicola ;
Vandermeer, Ben ;
Spooner, Carol ;
McAlister, Finlay A. .
ANNALS OF INTERNAL MEDICINE, 2007, 147 (04) :251-262
[10]   Genetic profiling as a marker for risk of sudden cardiac death [J].
Gollob, MH .
CURRENT OPINION IN CARDIOLOGY, 2006, 21 (01) :42-46